Nursing News and Research

Latest Nursing News and Research

Merck update on the status of telcagepant clinical development programs

Merck & Co., Inc. today updated the status of the clinical development programs for telcagepant (MK-0974) and MK-3207, the Company's investigational oral calcitonin gene-related peptide (CGRP) receptor antagonists for the intermittent treatment of acute migraine.

11 Sep 2009

Better use of quality-of-care ratings can lead to greater consumer control

A hospital pneumonia survival rate of 93 percent may sound good, but knowing that it's actually merely "fair" can help people pick a better hospital, according to new research. A "good" survival rate would be from 95 percent to 98 percent, medical experts say.

11 Sep 2009

Social identity has a positive impact on health and well-being

The quality of a person's social life could have an even greater impact than diet and exercise on their health and well-being. There is growing evidence that being a member of a social group can significantly reduce the risk of conditions like stroke, dementia and even the common cold.

11 Sep 2009

SafeTrace Tx software deployed in Schuylkill Health of Pottsville

Global Med Technologies((R)), Inc. ("Global Med" or the "Company"), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies division has licensed and deployed its SafeTrace Tx((R)) transfusion management software to Schuylkill Health of Pottsville, Pennsylvania.

11 Sep 2009

FDA approves Supplemental New Drug Application for DOXIL

Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its Supplemental New Drug Application (sNDA) for DOXIL (doxorubicin HCI liposome injection) in combination with docetaxel for the treatment of women with locally advanced and metastatic breast cancer.

10 Sep 2009

The first CardioGraft patch with MatrACELL technology implant performed

LifeNet Health, a leading allograft bio-implant company, announces the first implant of a CardioGraft(TM) allograft cardiac patch product with MatrACELL(TM)( )decellularization technology. The surgery was performed at Children's Mercy Hospital in Kansas City, Mo by Gary K. Lofland, MD, FACS, Section Chief, Cardiovascular Surgery at Children's Mercy Hospital in Kansas City, Mo, The Joseph Boon Gregg/Missouri Endowed Chair in Pediatric Cardiac Surgery, Professor of Surgery, UMKC.

10 Sep 2009

Capsule launches new Enterprise Medical Device Connectivity Solution

Capsule (www.capsuletech.com), the leading provider of medical device connectivity, today announces the release of their new Enterprise Medical Device Connectivity Solution enabled by the Capsule Neuron™.

10 Sep 2009

Amedisys in negotiations with Hackensack University Medical Center to acquire its home health operations

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice nursing companies, today announced that it is in discussions to acquire the home health operations of Hackensack University Medical Center.

10 Sep 2009

St. Vincent develops the first-ever HIV educational widget

Saint Vincent Catholic Medical Centers and the New York State Department of Health (DOH) today unveiled a novel Web-based technology to rapidly instruct health care providers throughout New York State about HIV diagnosis and prevention.

10 Sep 2009

Healthcare reform explained

A bevy of legislation is flooding Capitol Hill on healthcare reform. With President Obama’s speech kicking debate on these initiatives into high gear, Eric Zimmerman, a partner in the Health Law Department of leading law firm McDermott Will & Emery, weighs in on the issues:

10 Sep 2009

New protocol to tackle postpartum depression

Up to 80 percent of women experience depressive symptoms postpartum, with one in eight reporting the emergence of major depression within weeks of delivery.

10 Sep 2009

New type of stem cell in the prostate may be a source for prostate cancer, say researchers

A new type of stem cell discovered in the prostate of adult mice can be a source of prostate cancer, according to a new study by researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center and NewYork-Presbyterian Hospital.

10 Sep 2009

Clinical trial reveals RENOVA topical treatment cream shows continuous improvement

In 2008, the global anti-aging skincare market approached $15 billion, with 32 percent of U.S. facial skincare product launches boasting anti-aging claims many over-the-counter products are claiming to achieve comparable benefits as prescription anti-aging treatments.

10 Sep 2009

Merck's GARDASIL receives approval from FDA Advisory Committee

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.

10 Sep 2009

New electronic credentialing system for managed care organizations

OneBeacon Professional Partners, a member of OneBeacon Insurance Group (NYSE: OB), today announced an alliance with Medversant Technologies, LLC to offer OneBeacon managed care customers AutoVerifi(TM), a patented, electronic credentialing verification and management system that continuously validates, stores and retrieves records of medical providers.

9 Sep 2009

CEO Cancer Gold Standard accreditation for ASCO

The American Society of Clinical Oncology (ASCO) has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

9 Sep 2009

ETS to review RWJF New Careers in Nursing Scholarship Program

Educational Testing Service today announced that the Robert Wood Johnson Foundation approved a $299,827 award to ETS for the purpose of evaluating the RWJF New Careers in Nursing Scholarship Program. The grant period will run from July 15, 2009 to January 15, 2012.

9 Sep 2009

Maxim Health to launch its annual influenza vaccination program on October 1

It is the start of the flu season and with seasonal influenza responsible for more than 36,000 deaths per year, getting a flu vaccine is critical. Today, Maxim Health Systems announced on October 1 it will launch its annual influenza vaccination program and will provide flu shots nationwide through more than 44,000 clinics.

9 Sep 2009

Consortium awarded $3.75M to set up an AIDS research center in Chicago

The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.

9 Sep 2009

Care-Tech Laboratories consents to end illegal manufacture and marketing of OTC drugs

The U.S. Food and Drug Administration today announced that St. Louis-based Care-Tech Laboratories Inc. and its principal officers, John C. Brereton and Sherry L. Brereton, have signed a consent decree, agreeing to stop the illegal manufacture, marketing, and distribution of over-the-counter (OTC) antimicrobial drugs used to treat and prevent infection.

9 Sep 2009